Antisense Therapeutics Ltd
ASX:ANP

Watchlist Manager
Antisense Therapeutics Ltd Logo
Antisense Therapeutics Ltd
ASX:ANP
Watchlist
Price: 0.084 AUD 1.2% Market Closed
Market Cap: 75.7m AUD

Wall Street
Price Targets

ANP Price Targets Summary
Antisense Therapeutics Ltd

There are no price targets for ANP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Antisense Therapeutics Ltd Competitors:
Price Targets
ROG
Roche Holding AG
1% Downside
TARS
Tarsus Pharmaceuticals Inc
12% Upside
4523
Eisai Co Ltd
13% Upside
REC
Recordati Industria Chimica e Farmaceutica SpA
26% Upside
1093
CSPC Pharmaceutical Group Ltd
28% Upside
PBH
Prestige Consumer Healthcare Inc
27% Upside
XERS
Xeris Biopharma Holdings Inc
68% Upside

Revenue
Forecast

Revenue Estimate
Antisense Therapeutics Ltd

For the last 8 years the compound annual growth rate for Antisense Therapeutics Ltd's revenue is -25%. The projected CAGR for the next 3 years is 107%.

-25%
Past Growth
107%
Estimated Growth
Estimates Accuracy
-98%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Antisense Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Antisense Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ANP's stock price target?
Not Available

ANP doesn't have any price targets made by Wall Street professionals.

What is Antisense Therapeutics Ltd's Revenue forecast?
Projected CAGR
107%

For the last 8 years the compound annual growth rate for Antisense Therapeutics Ltd's revenue is -25%. The projected CAGR for the next 3 years is 107%.

Back to Top